Test ID LPMGF Lymphocyte Proliferation to Mitogens, Blood
Useful For
Assessing T-cell function in patients on immunosuppressive therapy, including solid-organ transplant patients
Evaluating patients suspected of having impairment in cellular immunity
Evaluation of T-cell function in patients with primary immunodeficiencies, either cellular (DiGeorge syndrome, T-negative severe combined immunodeficiency: SCID, etc) or combined T- and B-cell immunodeficiencies (T- and B-negative SCID, Wiskott Aldrich syndrome, ataxia telangiectasia, common variable immunodeficiency, among others) where T-cell function may be impaired
Evaluation of T-cell function in patients with secondary
immunodeficiency, either disease related or iatrogenic
Evaluation of recovery of T-cell function and competence following bone marrow transplantation or hematopoietic stem cell transplantation
Method Name
Flow Cytometry
Reporting Name
Lymphocyte Proliferation, MitogensSpecimen Type
WB Sodium HeparinSpecimens are required to be received in the laboratory weekdays and by 4 p.m. on Friday. It is recommended that specimens arrive within 24 hours of draw. Specimens arriving on the weekend may be canceled. Draw and package specimen as close to shipping time as possible. Ship specimen overnight in an Ambient Mailer-Critical Specimens Only (Supply T668).
Container/Tube: Green top (sodium heparin)
Specimen Volume:
<3 months: 1 mL
3 months-5 years: 2 mL
6-18 years: 3 mL
>18 years: 10 mL
Collection Instructions:
1. Send specimen is original tube. Do not aliquot.
2. Ship specimen overnight in an Ambient Mailer-Critical Specimens Only (Supply T668).
Additional Information:
1. Date and time of draw and ordering physician name and phone number are required.
2. Specify "Mitogen" to differentiate from "Antigen" testing. This information is required.
3. If both antigens and mitogens are desired, order LPMAF / Lymphocyte Proliferation Panel for Mitogens and Antigens.
4. For serial monitoring, we recommend that specimen draws be performed at the same time of day.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
WB Sodium Heparin | Ambient | 48 hours |
Clinical Information
The method of determining impaired T-cell function by culturing
human peripheral blood mononuclear cells (PBMC) in vitro with
mitogenic plant lectins (mitogens) such as phytohemagglutinin (PHA)
and pokeweed mitogen (PWM) has been part of the diagnostic
immunology repertoire for many years.(1,2) The widely used method
for assessing lymphocyte proliferation has hitherto been the
measurement of 3H-thymidine incorporated into the DNA of
proliferating cells. The disadvantages with the 3H-thymidine method
of lymphocyte proliferation are:
1. The technique is cumbersome due to the use of radioactivity
2. It does not allow discrimination of responding cell populations in response to stimulation
3. It does not provide any information on contribution of activation-induced cell death to the interpretation of the final result
Further, decreased lymphocyte proliferation could be due to several factors, including overall diminution of T-cell proliferation or decrease in proliferation of only a subset of T cells, or an apparent decrease in total lymphocyte proliferation due to T-cell lymphopenia and under-representation of T cells in the PBMC pool. None of these can be discriminated by the thymidine uptake assay, but can be assessed by flow cytometry, which uses antibodies to identify specific responder cell populations. Cell viability can also be measured within the same assay without requiring additional cell manipulation or specimen.
Mitogens are very potent stimulators of T-cell activation and proliferation independent of their antigenic specificity.(3) It has been suggested that mitogens can induce T-cell proliferative responses even if they are incapable of responding adequately to antigenic (physiologic) stimuli. Therefore, abnormal T-cell responses to mitogens are considered a diagnostically less sensitive but more specific test of aberrant T-cell function. Lectin mitogens have been shown to bind the T-cell receptor, which is glycosylated through its carbohydrate moiety, thereby activating quiescent T cells. Mitogenic stimulation has been shown to increase intracellular calcium (CA++) in T cells, which is absolutely essential for T-cell proliferation. While PHA is a strong T-cell mitogen, PWM is a weak T-cell mitogen, but it also induces B-cell activation and proliferation as well.
For this assay, we use a method that directly measures the S-phase proliferation of lymphocytes through the use of Click chemistry. In the Invitrogen Click-iT-EdU assay, the Click chemistry has been adapted to measure cell proliferation through direct detection of nucleotide incorporation. In the assay, an alkyne-modified nucleoside is supplied in cell-growth media for a defined time period and is incorporated within cells. The cells are subsequently fixed, permeabilized, and reacted with a dye-labeled azide, catalyzed by copper. A covalent bond is formed between the dye and the incorporated nucleotide, and the fluorescent signal is then measured by flow cytometry.(4) Specific proliferating cell populations can be visualized by the addition of cell-specific antibodies. Cell viability, apoptosis, and death can also be measured by flow cytometry using 7-AAD and Annexin V.
The Click-iT-EdU assay has already been shown to be an acceptable alternative to the 3H-thymidine assay for measuring lymphocyte/T-cell proliferation.(5)
The absolute counts of lymphocyte subsets are known to be influenced by a variety of biological factors, including hormones, the environment, and temperature. The studies on diurnal (circadian) variation in lymphocyte counts have demonstrated progressive increase in CD4 T-cell count throughout the day, while CD8 T cells and CD19+ B cells increase between 8:30 am and noon, with no change between noon and afternoon. Natural killer (NK)-cell counts, on the other hand, are constant throughout the day. Circadian variations in circulating T-cell counts have been shown to be negatively correlated with plasma cortisol concentration. In fact, cortisol and catecholamine concentrations control distribution and, therefore, numbers of naive versus effector CD4 and CD8 T cells. It is generally accepted that lower CD4 T-cell counts are seen in the morning compared with the evening, and during summer compared to winter. These data, therefore, indicate that timing, and consistency in timing, of blood collection is critical when serially monitoring patients for lymphocyte subsets.
Reference Values
Viability of lymphocytes at day 0: ≥75.0%
Maximum proliferation of phytohemagglutinin as % CD45: ≥49.9%
Maximum proliferation of phytohemagglutinin as % CD3: ≥58.5%
Maximum proliferation of pokeweed mitogen as % CD45: ≥4.5%
Maximum proliferation of pokeweed mitogen as % CD3: ≥3.5%
Maximum proliferation of pokeweed mitogen as % CD19: ≥3.9%
Cautions
When interpreting results it should be kept in mind that the range of lymphocyte proliferative responses observed in healthy, immunologically competent individuals is large. The reference ranges provided will be helpful in ascertaining the magnitude of the normal response.
Lymphocyte proliferation to mitogens is known to be affected by concomitant use of steroids, immunosuppressive agents, including cyclosporine, tacrolimus (FK506), Cellcept (mycophenolate mofetil), immunomodulatory agents, alcohol, and physiological and social stress.
Specimens >24-hours old may give spurious results.
Diminished results may be obtained in cultures that contain excess neutrophils or nonviable cells.(7)
Timing and consistency in timing of blood collection is critical when serially monitoring patients for lymphocyte subsets. See data under Clinical Information.
Day(s) Performed
Monday through Friday
Do not send specimen after Thursday.
Report Available
8 daysPerforming Laboratory

Test Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.CPT Code Information
86353